Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 5/20 | 0.53 |
| ▸ | PIM1 | P11309 | 1/20 | 0.47 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.47 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.47 |
| ▸ | PARP14 | Q460N5 | 11/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | AHR | P35869 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29882533 | 0.87 | GLA (0.50) | KIF11PARP14MEN1MAPTKMT2A | |
| SCHEMBL2568513 | 0.87 | GLA (0.50) | KIF11PARP14MEN1MAPTKMT2A | |
| SCHEMBL3373773 | 0.87 | GLA (0.50) | KIF11PARP14MEN1MAPTKMT2A | |
| SCHEMBL30641449 | 0.87 | KIF11 (0.57) | KIF11PARP14BCHE | |
| SCHEMBL208888 | 0.87 | KIF11 (0.57) | KIF11PARP14BCHE | |
| SCHEMBL1326376 | 0.87 | KIF11 (0.57) | KIF11PARP14BCHE | |
| SCHEMBL38828 | 0.87 | KIF11 (0.57) | KIF11PARP14BCHE | |
| SCHEMBL29407801 | 0.87 | KIF11 (0.57) | KIF11PARP14BCHE | |
| SCHEMBL17515019 | 0.85 | KIF11 (0.58) | KIF11PIM1PIM3PIM2PARP14 | |
| SCHEMBL28007630 | 0.85 | KIF11 (0.54) | KIF11PIM1PIM3PIM2PARP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119095403-B | Method for preparing high-stability perovskite solar cell | 中矿资源(天津)新材料有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119095403-A | Method for preparing high-stability perovskite solar cell | 中矿资源(天津)新材料有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-109020967-B | Organic compound capable of emitting yellow light, micron sheet thereof, preparation method and application | 龙岩学院 | 2021-06-08 | — | — | CN | claimed |
| CN-109020967-A | A kind of organic compound and its micron chip, preparation method and application of Yellow light-emitting low temperature | 龙岩学院 | 2018-12-18 | — | — | CN | claimed |
| US-8779128-B2 | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups | SAREPTA THERAPEUTICS, INC. (US) | 2014-07-15 | — | — | US | claimed |
| CN-102911111-B | Carbazole benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof | SHANDONG INST LIGHT INDUSTRY | 2014-06-11 | — | — | CN | claimed |
| CN-102898353-B | Carbazole benzaldehyde o-phenylenediamine bis-schiff base and preparation method thereof | UNIV QILU TECHNOLOGY | 2014-05-07 | — | — | CN | claimed |
| CN-102604412-B | Bis-carbazole group containing dye for dye-sensitized solar cells and preparation method of bis-carbazole group containing dye | UNIV BEIJING NORMAL | 2014-03-26 | — | — | CN | claimed |
| EP-2576574-A2 | OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS | Sarepta Therapeutics, Inc. (US) | 2013-04-10 | — | — | EP | claimed |
| CN-102911111-A | Carbazole benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof | SHANDONG INST LIGHT INDUSTRY | 2013-02-06 | — | — | CN | claimed |
| CN-102898353-A | Carbazole benzaldehyde o-phenylenediamine bis-schiff base and preparation method thereof | SHANDONG INST LIGHT INDUSTRY | 2013-01-30 | — | — | CN | claimed |
| CN-102604412-A | Bis-carbazole group containing dye for dye-sensitized solar cells and preparation method of bis-carbazole group containing dye | UNIV BEIJING NORMAL | 2012-07-25 | — | — | CN | claimed |
| US-20120065169-A1 | OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS | JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT | 2012-03-15 | — | — | US | claimed |
| WO-2011150408-A2 | OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS | AVI BIOPHARMA, INC. (US) | 2011-12-01 | — | — | WO | claimed |
| CN-101481611-A | Novel organic luminescent material containing p-carbazole cinnamenyl structure, as well as synthesizing method and use thereof | UNIV ZHONGSHAN (CN) | 2009-07-15 | — | — | CN | claimed |
| WO-2002020694-A1 | LOW MOLECULAR CHROMOPHORE COMPOUNDS AND ELECTROLUMINESCENCE DISPLAY DEVICE COMPRISING THE SAME | VISTORM CO., LTD. (KR) | 2002-03-14 | — | — | WO | claimed |
| CN-119095403-B | Method for preparing high-stability perovskite solar cell | 中矿资源(天津)新材料有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119095403-A | Method for preparing high-stability perovskite solar cell | 中矿资源(天津)新材料有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-101481611-A | Novel organic luminescent material containing p-carbazole cinnamenyl structure, as well as synthesizing method and use thereof | UNIV ZHONGSHAN (CN) | 2009-07-15 | — | — | CN | disclosed |
| WO-2002020694-A1 | LOW MOLECULAR CHROMOPHORE COMPOUNDS AND ELECTROLUMINESCENCE DISPLAY DEVICE COMPRISING THE SAME | VISTORM CO., LTD. (KR) | 2002-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065169-A1 | OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS | NSUN2, UPF1, RTCB | KIF11 2391/4885PIM1 3601/4885PIM3 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.